AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

Health

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

Mon, Oct 20, 2025 0 Comments

Audio By Carbonatix

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial.

(Reporting by Puyaan Singh in Bengaluru)

Previous Exclusive-Kabul must rein in militants for ceasefire to hold, says Pakistan

Next Chinese battery maker CATL posts faster profit growth in third quarter

Salem News Channel | Today

More Health Headlines

The Media Line: Lifestyle Changes May Protect Against Diabetes Even After Weight Regain: Ben-Gurion Study
Humana divests minority stake in hospice provider Gentiva
OB-GYN group makes vaccine recommendations for the first time
Health sleuths are watching for disease threats during the World Cup
Motorcycle taxi drivers in Congo rally for Ebola awareness as attacks hinder response

Other News to Consider

Follow SRNNews.com

on Facebook

@SRNNews

Subscribe to our Newsletters RSS Feeds

X CLOSE

Email to a Friend

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial. (Reporting by Puyaan Singh in Bengaluru)

X close